These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32722302)

  • 1. Telomeres and Telomerase in the Development of Liver Cancer.
    In der Stroth L; Tharehalli U; Günes C; Lechel A
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
    Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
    J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of telomeres and telomerase in cirrhosis and liver cancer.
    Nault JC; Ningarhari M; Rebouissou S; Zucman-Rossi J
    Nat Rev Gastroenterol Hepatol; 2019 Sep; 16(9):544-558. PubMed ID: 31253940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERT promoter mutations in telomere biology.
    Heidenreich B; Kumar R
    Mutat Res Rev Mutat Res; 2017; 771():15-31. PubMed ID: 28342451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
    Donaires FS; Scatena NF; Alves-Paiva RM; Podlevsky JD; Logeswaran D; Santana BA; Teixeira AC; Chen JJ; Calado RT; Martinelli ALC
    PLoS One; 2017; 12(8):e0183287. PubMed ID: 28813500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
    Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
    Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
    Roake CM; Artandi SE
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28289249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence, functionality and abundance of the TERT promoter mutations.
    Rachakonda S; Hoheisel JD; Kumar R
    Int J Cancer; 2021 Dec; 149(11):1852-1862. PubMed ID: 34313327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TERT promoter mutations and telomeres during tumorigenesis.
    Lorbeer FK; Hockemeyer D
    Curr Opin Genet Dev; 2020 Feb; 60():56-62. PubMed ID: 32163830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and Effect of Telomerase and Telomeric Length in Stem Cells.
    Celtikci B; Erkmen GK; Dikmen ZG
    Curr Stem Cell Res Ther; 2021; 16(7):809-823. PubMed ID: 32321410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data.
    Tornesello ML; Tornesello AL; Starita N; Cerasuolo A; Izzo F; Buonaguro L; Buonaguro FM
    Expert Opin Ther Targets; 2022 Sep; 26(9):767-780. PubMed ID: 36369706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
    J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescence and immortalization: role of telomeres and telomerase.
    Shay JW; Wright WE
    Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis.
    Piciocchi M; Cardin R; Cillo U; Vitale A; Cappon A; Mescoli C; Guido M; Rugge M; Burra P; Floreani A; Farinati F
    Transl Res; 2016 Feb; 168():122-133. PubMed ID: 26408804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
    Oh BK; Jo Chae K; Park C; Kim K; Jung Lee W; Han KH; Nyun Park Y
    J Hepatol; 2003 Nov; 39(5):786-92. PubMed ID: 14568262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
    Cevik D; Yildiz G; Ozturk M
    World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of telomeres in liver disease.
    Sunami Y; von Figura G; Kleger A; Strnad P; Hüser N; Hartmann D
    Prog Mol Biol Transl Sci; 2014; 125():159-72. PubMed ID: 24993702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres and telomerase: a dual role in hepatocarcinogenesis.
    Satyanarayana A; Manns MP; Rudolph KL
    Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the promoter of the telomerase gene
    Chiba K; Lorbeer FK; Shain AH; McSwiggen DT; Schruf E; Oh A; Ryu J; Darzacq X; Bastian BC; Hockemeyer D
    Science; 2017 Sep; 357(6358):1416-1420. PubMed ID: 28818973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.